Telephone +44(0)1284 728659
Email [email protected]
This Application Note illustrates how the smaller volume tubing reactor (810 mL) within a Dual-CoreTM element was used to determine optimal flow-through conditions suitable for the scale-up synthesis of the intermediate 3 required for the preparation of UpJohn’s oxazolidinone antibiotic linezolid (Zyvox®).